27 Sep 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Takeda Pharmaceutical has been selected for the third consecutive year for the Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific), the Asia Pacific version of the Dow Jones Sustainability Indexes (DJSI), which is one of the world's premier indices for Socially Responsible Investment (SRI).
Jointly compiled by Dow Jones, US, and Sustainable Asset Management (SAM), Switzerland, DJSI is a leading SRI index which assesses and selects leading sustainability-driven companies in terms of economic, environmental, and social criteria, and serves as one of the most important indices for investors who take into consideration the corporate social responsibility (CSR) initiatives of each company.
Specifically designed for companies in the developed Asia Pacific markets including Japan, DJSI Asia Pacific has captured 154 companies, including 74 Japanese companies, which are leading the way in terms of sustainability among the 600 companies in the region.
For inclusion in the DJSI Asia Pacific, SAM assesses companies based on questionnaire responses, annual reports, and other publications from each company. Takeda has been included in the DJSI Asia Pacific for the third consecutive year for its outstanding performance based on the three criteria above. In addition to DJSI Asia Pacific, Takeda has also been included in the FTSE4Good Global Index and Morningstar Socially Responsible Investment Index (MS-SRI), both of which are also benchmark SRI indexes.